Persistent blood DNA methylation changes one year after SARS-CoV-2 infection
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1868-7083
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Persistent blood DNA methylation changes one year after SARS-CoV-2 infection ; volume:14 ; number:1 ; day:23 ; month:7 ; year:2022 ; pages:1-5 ; date:12.2022
Clinical epigenetics ; 14, Heft 1 (23.7.2022), 1-5, 12.2022
- Urheber
-
Balnis, Joseph
Madrid, Andy
Hogan, Kirk J.
Drake, Lisa A.
Adhikari, Anish
Vancavage, Rachel
Singer, Harold A.
Alisch, Reid S.
Jaitovich, Ariel
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13148-022-01313-8
- URN
-
urn:nbn:de:101:1-2022100521364853096527
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Balnis, Joseph
- Madrid, Andy
- Hogan, Kirk J.
- Drake, Lisa A.
- Adhikari, Anish
- Vancavage, Rachel
- Singer, Harold A.
- Alisch, Reid S.
- Jaitovich, Ariel
- SpringerLink (Online service)
Ähnliche Objekte (12)
Relationship of SARS-CoV-2 Pandemic with Blood Groups
Prevalence of persistent SARS-CoV-2 in a large community surveillance study
SARS-CoV-2 quasi-species analysis from patients with persistent nasopharyngeal shedding
Whole blood DNA methylation analysis reveals respiratory environmental traits involved in COVID-19 severity following SARS-CoV-2 infection
Persistent SARS-CoV-2 PCR Positivity Despite Anti-viral Treatment in Immunodeficient Patients
Management of SARS-CoV-2 and Persistent Viral Detection in Solid Organ Transplant Recipients
Sex and ABO Blood Differences in SARS-CoV-2 Infection Susceptibility
ABO blood groups and the risk of SARS-CoV-2 infection
Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2
SARS-CoV-2-Arbeitsschutzstandard
Persistent but atypical germinal center reaction among 3rd SARS-CoV-2 vaccination after rituximab exposure
Persistent SARS-CoV-2-positive over 4 months in a COVID-19 patient with CHB
Relationship of SARS-CoV-2 Pandemic with Blood Groups
Prevalence of persistent SARS-CoV-2 in a large community surveillance study
SARS-CoV-2 quasi-species analysis from patients with persistent nasopharyngeal shedding
Whole blood DNA methylation analysis reveals respiratory environmental traits involved in COVID-19 severity following SARS-CoV-2 infection
Persistent SARS-CoV-2 PCR Positivity Despite Anti-viral Treatment in Immunodeficient Patients
Management of SARS-CoV-2 and Persistent Viral Detection in Solid Organ Transplant Recipients
Sex and ABO Blood Differences in SARS-CoV-2 Infection Susceptibility
ABO blood groups and the risk of SARS-CoV-2 infection
Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2
SARS-CoV-2-Arbeitsschutzstandard
Persistent but atypical germinal center reaction among 3rd SARS-CoV-2 vaccination after rituximab exposure
Persistent SARS-CoV-2-positive over 4 months in a COVID-19 patient with CHB
Relationship of SARS-CoV-2 Pandemic with Blood Groups
Prevalence of persistent SARS-CoV-2 in a large community surveillance study
SARS-CoV-2 quasi-species analysis from patients with persistent nasopharyngeal shedding
Whole blood DNA methylation analysis reveals respiratory environmental traits involved in COVID-19 severity following SARS-CoV-2 infection
Persistent SARS-CoV-2 PCR Positivity Despite Anti-viral Treatment in Immunodeficient Patients
Management of SARS-CoV-2 and Persistent Viral Detection in Solid Organ Transplant Recipients
Sex and ABO Blood Differences in SARS-CoV-2 Infection Susceptibility
ABO blood groups and the risk of SARS-CoV-2 infection
Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2
SARS-CoV-2-Arbeitsschutzstandard
Persistent but atypical germinal center reaction among 3rd SARS-CoV-2 vaccination after rituximab exposure